Clinical Trial Update: Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluates the efficacy of adding HIPEC to systemic chemotherapy and cytoreductive surgery for peritoneal metastases from gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Carcinomatosis

Snippet

Sponsor: Shu-Zhong Cui | Conditions: Gastric Cancer, Peritoneal Carcinomatosis | Phase 3 | Status: UNKNOWN